Details of the Drug

General Information of Drug (ID: DMZ6PRF)

• Drug Name: HB-adipose-derived mesenchymal stem cells
• Synonyms: HB-adMSCs

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D01IKM

References

• [1] ClinicalTrials.gov (NCT04349631) A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19. U.S. National Institutes of Health.